Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells

New England Journal of Medicine

Volumn 317, Issue 9, 1987, Pages 526-532

  Garrett, I Ross ^a,b,c,d   Durie, Brian G m ^a,b,c,d   Nedwin, Glenn E ^a,b,c,d   Gillespie, Alison ^a,b,c,d   Bringman, Timothy ^a,b,c,d   Sabatini, Massimo ^a,b,c,d   Bertolini, Donald R ^a,b,c,d   Mundy, Gregory R ^a,b,c,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF ARIZONA MEDICAL CENTER   (United States)

^c Molecular Therapeutics ^*  (United States)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

BONE; BONE DESTRUCTION; CELL CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MYELOMA CELL; PRIORITY JOURNAL;

EID: 0023227925     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198708273170902     Document Type: Article

References (38)

1. Mundy GR. Ibbotson KJ. D'Souza SM. Simpson EL, Jacobs JW, Martin TJ. The hypercalcemia of cancer: clinical implications and pathogenic mechanisms. N Engl J Med 1984; 310: 1718–27.
2. Mundy GR. Raisz LG, Cooper RA. Schechter GP, Salmon SE. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 1974; 291: 1041–6.
3. Valentin-Opran A, Charhon SA, Meunier PJ, Edouard CM, Arlot ME. Quantitative histology of myeloma-induced bone changes. Br J Haematol 1982; 52: 601–10.
4. Mundy GR, Luben RA, Raisz LG, Oppenheim JJ, Buell DN. Bone-resorbing activity in supernatants from lymphoid cell lines. N Engl J Med 1974; 290: 867–71.
5. Mundy GR. Ibbotson KJ, D'Souza SM. Tumor products and the hypercalcemia of malignancy. J Clin Invest 1985; 76: 391–4.
6. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 1983; 306: 378–80.
7. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319: 516–8.
8. Gowen M, Nedwin G, Mundy GR. Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. J Bone Miner Res 1986; 1: 469–74.
9. Rodriquez MA, Durie BG, Meltzer PS. Evidence that a subset of human myelomas contain Epstein–Barr virus. Proc Am Soc Clin Oncol 1985; 4: 13. abstract.
10. Ritts RE Jr. Ruiz-Arguelles, Weyl KG, et al. Establishment and characterization of a human non-secretory plasmacytoid cell line and its hybridization with human B cells. Int J Cancer 1983; 31: 133–41.
11. Diehl V, Schaadt M. Kirchner H. et al. Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study. Blut 1978; 36: 331–8.
12. Simmons JG, Fuller CR, Buchanan PD, Yount WJ. Distribution of surface, cytoplasmic and secreted IgG subclasses in human lymphoblastoid cell lines and normal peripheral blood lymphocytes. Scand J Immunol 1981; 14: 1–13.
13. Durie BGM. Vela E, Baum V, et al. Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal change. Blood 1985; 66: 548–55.
14. Raisz LG. Bone resorption in tissue culture: factors influencing the response to parathyroid hormone. J Clin Invest 1965; 44: 103–16.
15. Gray PW, Aggarwal BB. Benton CV, et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 1984; 312: 721–4.
16. Aggarwal BB, Moffat B, Harkins RN. Human lymphotoxin: production by a lymphobiastoid cell line, purification, and initial characterization. J Biol Chem 1984; 259: 686–91.
17. Pennica D, Nedwin GE, Hayflick JS, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724–9.
18. Wood WI, Gitschier J, Lasky LA, Lawn RM. Base composition-independent hybridization in tetramethyl-ammonium chloride: a method for oligonucleotide screening of highly complex gene libraries. Proc Natl Acad Sci USA 1985; 82: 1585–8.
19. Nedwin GE, Naylor SL, Sakaguchi AY, et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res 1985; 13: 6361–73.
20. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1982.
21. Berger SB, Birkenmeier CS. Inhibition of intractable nucleases with ribonucleoside-vanadyl complexes: isolation of messenger ribonucleic acid from resting lymphocytes. Biochemistry 1979; 18: 5143–9.
22. Thomas PS. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 1980; 77: 5201–5.
23. Gailani S, McLimans WF, Mundy GR, Nussbaum A, Roholt O, Zeigel R. Controlled environment culture of bone marrow expiants from human myeloma. Cancer Res 1976; 36: 1299–304.
24. Lomedico PT, Gubler U, Hellmann CP, et al. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 1984; 312: 458–62.
25. Abe E, Tanaka H, Ishimi Y, et al. Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci USA 1986; 83: 5958–62.
26. Snapper I, Kahn A. Myelomatosis. Basel, Switzerland: S. Karger, 1971.
27. Durie BGM, Salmon SE, Mundy GR. Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma. Br J Haematol 1981; 47: 21–30.
28. Heyburn PJ, Child JA, Peacock M. Relative importance of renal failure and increased bone resorption in the hypercalcemia of myelomatosis. J Clin Pathol 1981; 34: 54–7.
29. Mundy GR, Martin TJ. The hypercalcemia of malignancy: pathogenesis and management. Metabolism 1982; 31: 1247–77.
30. Bertolini DR, Sarin P, Mundy GR. Production of macromolecular bone resorbing activity by human T-cell leukemia virus (HTLV) transformed cell lines. Calcif Tissue Int 1984; 36: 452. abstract.
31. Breslau NA, McGuire JL, Zerwekh JE, Frenkel EP, Pak CYC. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 1984; 100: 1–7.
32. Fetchick DA, Bertolini DR, Sarin PS, Weintraub ST, Mundy GR, Dunn JF. Production of 1,25 dihydroxyvitamin D3 by human T cell lymphotropic virus-I-transformed lymphocytes. J Clin Invest 1986; 78: 592–6.
33. Salahuddin SZ, Markham PD, Lindner SG, et al. Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science 1984; 223: 703–7.
34. Horiuchi N, Holick MF, Potts JT Jr. Rosenblatt M. A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog. Science 1983; 220: 1053–5.
35. D'Souza SM, Ibbotson KJ, Mundy GR. Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy. J Clin Invest 1984; 74: 1104–7.
36. Beutler B, Greenwald D, Hulmes JD, et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985; 316: 552–4.
37. Gowen M, Mundy GR. Actions of recombinant interleukin-1, interleukin-2, and interferon gamma on bone resorption in vitro. J Immunol 1986; 136: 2478–82.
38. Takahashi N, Mundy GR, Roodman GD. Recombinant human interferon-γ inhibits formation of human osteoclast-like cells. J Immunol 1986; 137: 3544–9.